X
TNDM icon

Xponance’s Tandem Diabetes Care TNDM Stock Holding History

Xponance’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8,233
Closed -$334K – 1293
2023
Q1 		$334K Sell
8,233
-6,181
-43% -$256K ﹤0.01% 1018
2022
Q4 		$648K Buy
14,414
+814
+6% +$36.9K 0.01% 799
2022
Q3 		$651K Buy
13,600
+54
+0.4% +$2.96K 0.01% 732
2022
Q2 		$802K Buy
13,546
+616
+5% +$50.6K 0.02% 656
2022
Q1 		$1.5M Sell
12,930
-240
-2% -$28K 0.03% 457
2021
Q4 		$1.98M Buy
13,170
+400
+3% +$54K 0.03% 391
2021
Q3 		$1.52M Buy
12,770
+5,996
+89% +$661K 0.03% 424
2021
Q2 		$660K Buy
6,774
+1,106
+20% +$98.6K 0.01% 780
2021
Q1 		$500K Buy
5,668
+161
+3% +$15K 0.01% 782
2020
Q4 		$527K Sell
5,507
-3
-0.1% -$309 0.01% 711
2020
Q3 		$625K Buy
5,510
+135
+3% +$14.2K 0.02% 560
2020
Q2 		$532K Buy
+5,375
New +$429K 0.01% 581

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Xponance's TNDM Position: Q2 2023 in Review

Xponance sold out of Tandem Diabetes Care (TNDM) in Q2 2023, closing a stake of 8,233 shares — an estimated $334K sold.

Xponance first reported a position in TNDM in Q2 2020 and held it in 12 quarters. The position peaked at $1.98M in Q4 2021. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

  • Xponance reported no remaining Tandem Diabetes Care position as of Q2 2023 after selling out during the quarter.
  • Xponance sold 8,233 Tandem Diabetes Care shares in Q2 2023, an estimated $334K.
  • Xponance first reported a position in Tandem Diabetes Care in Q2 2020 and held it in 12 quarters.
  • Xponance's Tandem Diabetes Care position peaked at $1.98M in Q4 2021.
  • 247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on Xponance's 13F filing for Q2 2023, filed 14 Jul 2023.